| pubmed-article:11405642 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11405642 | lifeskim:mentions | umls-concept:C0243192 | lld:lifeskim |
| pubmed-article:11405642 | lifeskim:mentions | umls-concept:C0033482 | lld:lifeskim |
| pubmed-article:11405642 | lifeskim:mentions | umls-concept:C0166415 | lld:lifeskim |
| pubmed-article:11405642 | lifeskim:mentions | umls-concept:C0220781 | lld:lifeskim |
| pubmed-article:11405642 | lifeskim:mentions | umls-concept:C1823153 | lld:lifeskim |
| pubmed-article:11405642 | lifeskim:mentions | umls-concept:C1883254 | lld:lifeskim |
| pubmed-article:11405642 | lifeskim:mentions | umls-concept:C0456387 | lld:lifeskim |
| pubmed-article:11405642 | lifeskim:mentions | umls-concept:C2349976 | lld:lifeskim |
| pubmed-article:11405642 | lifeskim:mentions | umls-concept:C1552644 | lld:lifeskim |
| pubmed-article:11405642 | lifeskim:mentions | umls-concept:C1554184 | lld:lifeskim |
| pubmed-article:11405642 | lifeskim:mentions | umls-concept:C1707689 | lld:lifeskim |
| pubmed-article:11405642 | pubmed:issue | 13 | lld:pubmed |
| pubmed-article:11405642 | pubmed:dateCreated | 2001-6-14 | lld:pubmed |
| pubmed-article:11405642 | pubmed:abstractText | Propionic acid derivative 8, which was designed and synthesized based on putative pharmacophores of known PPARgamma- and PPARalpha-selective compounds, exhibits potent dual PPARalpha/gamma agonist activity as demonstrated by in vitro binding and dose overlap in the newly introduced EOB mouse model for glucose lowering and lipid/cholesterol homeostasis. | lld:pubmed |
| pubmed-article:11405642 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11405642 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11405642 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11405642 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11405642 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11405642 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11405642 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11405642 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11405642 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11405642 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11405642 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11405642 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:11405642 | pubmed:issn | 0022-2623 | lld:pubmed |
| pubmed-article:11405642 | pubmed:author | pubmed-author:KauffmanR FRF | lld:pubmed |
| pubmed-article:11405642 | pubmed:author | pubmed-author:McCarthyJ RJR | lld:pubmed |
| pubmed-article:11405642 | pubmed:author | pubmed-author:DominianniS... | lld:pubmed |
| pubmed-article:11405642 | pubmed:author | pubmed-author:BrooksD ADA | lld:pubmed |
| pubmed-article:11405642 | pubmed:author | pubmed-author:Montrose-Rafi... | lld:pubmed |
| pubmed-article:11405642 | pubmed:author | pubmed-author:RitoC JCJ | lld:pubmed |
| pubmed-article:11405642 | pubmed:author | pubmed-author:BroderickC... | lld:pubmed |
| pubmed-article:11405642 | pubmed:author | pubmed-author:KaranewskyD... | lld:pubmed |
| pubmed-article:11405642 | pubmed:author | pubmed-author:PaternitiJ... | lld:pubmed |
| pubmed-article:11405642 | pubmed:author | pubmed-author:WinneroskiL... | lld:pubmed |
| pubmed-article:11405642 | pubmed:author | pubmed-author:FaulM MMM | lld:pubmed |
| pubmed-article:11405642 | pubmed:author | pubmed-author:ShukerA JAJ | lld:pubmed |
| pubmed-article:11405642 | pubmed:author | pubmed-author:EtgenG JGJ | lld:pubmed |
| pubmed-article:11405642 | pubmed:author | pubmed-author:OldhamB ABA | lld:pubmed |
| pubmed-article:11405642 | pubmed:author | pubmed-author:WarshawskyA... | lld:pubmed |
| pubmed-article:11405642 | pubmed:author | pubmed-author:ArdeckyRR | lld:pubmed |
| pubmed-article:11405642 | pubmed:author | pubmed-author:TyhonasJJ | lld:pubmed |
| pubmed-article:11405642 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11405642 | pubmed:day | 21 | lld:pubmed |
| pubmed-article:11405642 | pubmed:volume | 44 | lld:pubmed |
| pubmed-article:11405642 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11405642 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11405642 | pubmed:pagination | 2061-4 | lld:pubmed |
| pubmed-article:11405642 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11405642 | pubmed:meshHeading | pubmed-meshheading:11405642... | lld:pubmed |
| pubmed-article:11405642 | pubmed:meshHeading | pubmed-meshheading:11405642... | lld:pubmed |
| pubmed-article:11405642 | pubmed:meshHeading | pubmed-meshheading:11405642... | lld:pubmed |
| pubmed-article:11405642 | pubmed:meshHeading | pubmed-meshheading:11405642... | lld:pubmed |
| pubmed-article:11405642 | pubmed:meshHeading | pubmed-meshheading:11405642... | lld:pubmed |
| pubmed-article:11405642 | pubmed:meshHeading | pubmed-meshheading:11405642... | lld:pubmed |
| pubmed-article:11405642 | pubmed:meshHeading | pubmed-meshheading:11405642... | lld:pubmed |
| pubmed-article:11405642 | pubmed:meshHeading | pubmed-meshheading:11405642... | lld:pubmed |
| pubmed-article:11405642 | pubmed:meshHeading | pubmed-meshheading:11405642... | lld:pubmed |
| pubmed-article:11405642 | pubmed:meshHeading | pubmed-meshheading:11405642... | lld:pubmed |
| pubmed-article:11405642 | pubmed:meshHeading | pubmed-meshheading:11405642... | lld:pubmed |
| pubmed-article:11405642 | pubmed:meshHeading | pubmed-meshheading:11405642... | lld:pubmed |
| pubmed-article:11405642 | pubmed:meshHeading | pubmed-meshheading:11405642... | lld:pubmed |
| pubmed-article:11405642 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11405642 | pubmed:articleTitle | Design and synthesis of 2-methyl-2-[4-(2-[5-methyl-2-aryloxazol-4-yl]ethoxy)phenoxy]propionic acids: a new class of dual PPARalpha/gamma agonists. | lld:pubmed |
| pubmed-article:11405642 | pubmed:affiliation | Lilly Research Laboratories, A Division of Eli Lilly & Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USA. Brooks_Dawn_A@Lilly.com | lld:pubmed |
| pubmed-article:11405642 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:11405642 | lld:chembl |
